Back to announcements list
Transaction in own shares and Issue of Equity
RNS Number : 7461Z
CT Global Managed Portfolio Trust
15 January 2024
 

TO:                  RNS

FROM:                        CT Global Managed Portfolio Trust PLC

DATE:             15 January 2024

SUBJECT:      Transaction in own shares and Issue of Equity

LEI:                  213800ZA6TW45NM9YY31

 

 

The Board of CT Global Managed Portfolio Trust PLC ("the Company") announces that on 15 January 2024 the Company purchased 60,000 Growth shares of £0.060600579 each at a price of 233.25p per Growth share to be held in treasury and allotted 175,000 Income shares of £0.060600579 each, from the Company's general business purposes blocklisting facility at a price of 113.25p per Income share. These Income shares will rank pari passu with the existing Income shares in issue and dealings are expected to commence on 17 January 2024.

 

Following this issue, the Company has the ability to issue 984,510 Income shares and 1,304,550 Growth shares under its blocklisting facilities.

 

Following this transaction the Company's issued share capital consists of 51,473,251 Income shares and 38,827,608 Growth shares, of which nil Income shares and 2,250,000 Growth shares are held in treasury. Therefore the total number of shares with voting rights in CT Global Managed Portfolio Trust PLC is 51,473,251 Income shares and 36,577,608 Growth shares.

 

The above figures (51,473,251 Income shares and 36,577,608 Growth shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CT Global Managed Portfolio Trust PLC under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Peter Hewitt, Columbia Threadneedle Investment Business Limited 0131 573 8360

Ian Ridge, Columbia Threadneedle Investment Business Limited       0131 573 8316

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBLGDBSBBDGSU